Literature DB >> 19870035

ANTIPNEUMOCOCCIC IMMUNITY REACTIONS IN INDIVIDUALS OF DIFFERENT AGES.

W D Sutliff1, M Finland.   

Abstract

1. The incidence of pneumococcidal power of the whole defibrinated blood in human beings has been shown to vary with age. The age distribution of other type-specific antibodies varies similarly, insofar as they are frequent enough to be compared or technically demonstrable. 2. The incidence of pneumococcidal power of the whole defibrinated blood for Type I, Type II, and Type III differs. Type I is the rarest, Type II is the most frequent, and Type III is of intermediate frequency. The type-specific antibodies responsible for the other tests employed show a similar relative frequency in regard to Types I and II, but some variation in regard to Type III. 3. The skin reactions to the acetic acid-predpitable proteins and autolysates of the pneumococci are negative or rarely positive in infants, infrequently positive in childhood, and positive in a high percentage of adults.

Entities:  

Year:  1932        PMID: 19870035      PMCID: PMC2132146          DOI: 10.1084/jem.55.6.837

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

1.  THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS : SECOND PAPER.

Authors:  M Heidelberger; O T Avery
Journal:  J Exp Med       Date:  1924-08-31       Impact factor: 14.307

2.  STUDIES ON IMMUNITY TO PNEUMOCOCCUS MUCOSUS (TYPE III) : I. ANTIBODY RESPONSE OF RABBITS IMMUNIZED WITH TYPE III PNEUMOCOCCUS.

Authors:  W S Tillett
Journal:  J Exp Med       Date:  1927-03-31       Impact factor: 14.307

3.  THE SOLUBLE SPECIFIC SUBSTANCE OF FRIEDLANDER'S BACILLUS : PAPER II. CHEMICAL AND IMMUNOLOGICAL RELATIONSHIPS OF PNEUMOCOCCUS TYPE II AND OF A STRAIN OF FRIEDLANDER'S BACILLUS.

Authors:  O T Avery; M Heidelberger; W F Goebel
Journal:  J Exp Med       Date:  1925-10-31       Impact factor: 14.307

4.  SPECIFIC ANTIBODY RESPONSE OF HUMAN SUBJECTS TO INTRACUTANEOUS INJECTION OF PNEUMOCOCCUS PRODUCTS.

Authors:  M Finland; W D Sutliff
Journal:  J Exp Med       Date:  1932-05-31       Impact factor: 14.307

5.  THE EPIDEMIOLOGY OF PNEUMOCOCCUS INFECTION : THE INCIDENCE AND SPREAD OF PNEUMOCOCCI IN THE NASAL PASSAGES AND THROATS OF HEALTHY PERSONS.

Authors:  L T Webster; T P Hughes
Journal:  J Exp Med       Date:  1931-03-31       Impact factor: 14.307

6.  REACTIONS OF RABBITS TO INTRACUTANEOUS INJECTIONS OF PNEUMOCOCCI AND THEIR PRODUCTS : VI. HYPERSENSITIVENESS TO PNEUMOCOCCI AND THEIR PRODUCTS.

Authors:  L A Julianelle
Journal:  J Exp Med       Date:  1930-03-31       Impact factor: 14.307

7.  SPECIFIC CUTANEOUS REACTIONS AND CIRCULATING ANTIBODIES IN THE COURSE OF LOBAR PNEUMONIA : I. CASES RECEIVING NO SERUM THERAPY.

Authors:  M Finland; W D Sutliff
Journal:  J Exp Med       Date:  1931-10-31       Impact factor: 14.307

8.  OBSERVATIONS ON THE PHAGOCYTOSIS OF THE PNEUMOCOCCUS BY HUMAN WHOLE BLOOD : I. THE NORMAL PHAGOCYTIC TITRE, AND THE ANTI-PHAGOCYTIC EFFECT OF THE SPECIFIC SOLUBLE SUBSTANCE.

Authors:  H K Ward
Journal:  J Exp Med       Date:  1930-04-30       Impact factor: 14.307

9.  HOST FACTORS IN THE PATHOGENESIS OF PNEUMOCOCCUS PNEUMONIA : I. THE REACTION OF THE LUNGS TO PNEUMOCOCCUS AUTOLYSATE IN SENSITIZED RABBITS.

Authors:  E A Sharp; F G Blake
Journal:  J Exp Med       Date:  1930-09-30       Impact factor: 14.307

10.  THE RELATION OF NATURAL HUMORAL ANTIPNEUMOCOCCAL IMMUNITY TO THE INCEPTION OF LOBAR PNEUMONIA.

Authors:  O H Robertson; E E Terrell; J B Graeser; M A Cornwell
Journal:  J Exp Med       Date:  1930-08-31       Impact factor: 14.307

View more
  6 in total

Review 1.  Diagnosis and management of bacterial meningitis.

Authors:  G Hambleton; P A Davies
Journal:  Drugs       Date:  1974       Impact factor: 9.546

2.  Splenic preservation in children.

Authors:  R J Touloukian
Journal:  World J Surg       Date:  1985-04       Impact factor: 3.352

3.  Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates.

Authors:  R Schneerson; J B Robbins; C Chu; A Sutton; W Vann; J C Vickers; W T London; B Curfman; M C Hardegree; J Shiloach
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

4.  SPECIFIC ANTIBODY RESPONSE OF HUMAN SUBJECTS TO INTRACUTANEOUS INJECTION OF PNEUMOCOCCUS PRODUCTS.

Authors:  M Finland; W D Sutliff
Journal:  J Exp Med       Date:  1932-05-31       Impact factor: 14.307

5.  CHANGES IN THE TITER OF ANTIPNEUMOCOCCAL HUMORAL IMMUNITY IN ADULT HUMAN BEINGS.

Authors:  J B Graeser; M C Harrison
Journal:  J Exp Med       Date:  1933-07-31       Impact factor: 14.307

6.  IMMUNITY REACTIONS OF HUMAN SUBJECTS TO STRAINS OF PNEUMOCOCCI OTHER THAN TYPES I, II AND III.

Authors:  M Finland; W D Sutliff
Journal:  J Exp Med       Date:  1933-01-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.